Molecular stability overrides size in giant pediatric pheochromocytoma.

J Pediatr Endocrinol MetabAug 14, 2026 (epub)

Enver Simsek, Hüseyin İlhan, Murat Yilmaz et al.

✦ AI-curated · Sources linked

Case in brief

A 16-year-old female presented with severe hypertension and hyperglycemia, initially misdiagnosed with essential hypertension and type 2 diabetes. Imaging revealed a 12.4 cm adrenal mass, and biochemical tests indicated significant catecholamine excess. After open total adrenalectomy, the patient achieved biochemical normalization and favorable follow-up, despite the tumor's large size and multifocal lymphovascular invasion.

What made this case unusual

The case is notable for the preserved expression of succinate dehydrogenase subunit B (SDHB) and a low Ki-67 proliferation index, despite the tumor's large size and aggressive features.

Diagnostic / clinical pearl

Clinicians should consider pheochromocytoma in pediatric patients with persistent hypertension and atypical metabolic abnormalities, as traditional size metrics may not predict tumor behavior.

Why it matters

This case underscores the need for integrating molecular markers in the assessment of pheochromocytoma to enhance risk stratification and inform clinical management.

Source

Published in J Pediatr Endocrinol Metab. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.